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Abstract 20 
 21 
Protein secretion mechanisms are essential for the virulence of most bacterial 22 
pathogens. Typhoid toxin is an essential virulence factor for Salmonella Typhi, the 23 
cause of typhoid fever in humans. This toxin is unique in that it is only produced 24 
within mammalian cells, and it must be trafficked to the extracellular space prior 25 
to intoxicating target cells. An essential and poorly understood aspect of this 26 
transport pathway is the secretion of typhoid toxin from the bacterium into the S. 27 
Typhi-containing vacuole. We show here that typhoid toxin secretion requires its 28 
translocation to the trans side of the peptidoglycan layer at the bacterial poles for 29 
subsequent release through the outer membrane. This translocation process 30 
depends on a specialized muramidase, whose activity requires the localized 31 
editing of peptidoglycan by a specific LD-transpeptidase. These studies describe 32 
a novel protein export mechanism that is likely conserved in other bacterial 33 
species.  34 
 35 
 3
 36 
The interaction of pathogenic bacteria with their respective hosts often involves 37 
bacterially encoded proteins that must be transported across the bacterial envelope so 38 
that they can reach their destination on target eukaryotic cells. Protein transport across 39 
the bacterial envelope is particularly challenging in Gram-negative bacteria, where to 40 
reach the outside, proteins must first move through at least three barriers, the inner 41 
membrane, the peptidoglycan layer, and the outer membrane. Consequently, bacterial 42 
pathogens have evolved a variety of sophisticated protein secretion systems that can 43 
direct proteins to the extracellular environment or even directly into eukaryotic cells 1-4. 44 
The Gram-negative bacterial pathogen Salmonella enterica serovar Typhi (S. Typhi) is 45 
the cause of typhoid fever, a systemic disease of humans that remains a global health 46 
concern 5-9. Typhoid toxin is an essential virulence factor of this pathogen and it is 47 
believed to be largely responsible for the acute, life-threatening symptoms of typhoid 48 
fever 10-12. This toxin, which is encoded within a discrete genomic islet (Supplementary 49 
Fig. 1), has a unique A2B5 architecture with two covalently linked enzymatic “A” subunits, 50 
PltA and CdtB, associated to a homopentameric “B” subunit made up of PltB 11. A 51 
unique feature of typhoid toxin is that it is exclusively expressed in intracellularly 52 
localized bacteria 10,13,14. This unique pattern of gene expression is the result of a 53 
silencing and counter-silencing transcriptional regulatory mechanism through the 54 
opposing actions of the PhoP/PhoQ two-component regulatory system and the histone-55 
like protein H-NS 14. Once synthesized and exported to the periplasmic space by the 56 
sec-dependent pathway, the toxin is assembled into a 115-kDa multimeric complex, 57 
which is secreted into the lumen of the S. Typhi-containing vacuole. The toxin is then 58 
packaged into vesicle carrier intermediates, which transport it to the extracellular space 59 
from where it can reach its targets 10,15. The mechanism by which the toxin is secreted 60 
from the bacteria into the lumen of its enclosing phagocytic vacuole is not understood, 61 
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although it is known to require the ttsA gene, which is encoded within the same locus as 62 
the typhoid toxin genes (Supplementary Fig. 1), and is predicted to encode a homolog of 63 
bacteriophage N-acetyl-β-D-muramidases 16. Here we show that TtsA mediates the 64 
translocation of typhoid toxin from the cis to the trans side of the peptidoglycan layer, 65 
positioning the toxin within a compartment from where it can be rapidly released by 66 
membrane active compounds encountered by S. Typhi within its intracellular 67 
environment. We found that TtsA activity requires the editing of the peptidoglycan at the 68 
bacterial poles by a specific LD-transpeptidase, which is essential for toxin secretion. 69 
This study describes a novel protein export mechanism likely conserved in other 70 
bacterial pathogens, which has evolved to ensure the release of a toxin in the 71 
appropriate environment.  72 
 73 
Results  74 
 75 
TtsA-dependent translocation and agonist-mediated release of typhoid toxin after 76 
S. Typhi growth in vitro. Since typhoid toxin is exclusively produced within infected 77 
cells, the immunofluorescence microscopy visualization of vesicle carrier intermediates 78 
has been the only surrogate assay available to study typhoid toxin secretion from 79 
bacterial cells (Supplementary Fig. 2) 16, an assay poorly suited for mechanistic studies. 80 
We have recently unraveled the regulatory network that controls the exclusive 81 
intracellular expression of typhoid toxin 14. This information has allowed us to identify in 82 
vitro culture conditions that closely mimic those encountered by bacteria within 83 
mammalian cells 17 and that are therefore permissive for typhoid toxin and TtsA 84 
expression at levels equivalent to those in infected cells (Fig. 1a and Supplementary Fig. 85 
2) 14,16,18. Using these growth conditions (henceforth referred to as “typhoid toxin 86 
inducing media” or TTIM) we examined the TtsA-dependent secretion of typhoid toxin 87 
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into culture supernatants monitored through the detection of its CdtB subunit. 88 
Surprisingly, we did not detect typhoid toxin in culture supernatants or on the surface of 89 
bacteria grown under these conditions, although we readily detected it in whole bacterial 90 
lysates (Fig. 1b and 1c). However, we found that the addition of a very low amount of 91 
detergent (0.1% Triton X-100) to bacterial cells, which did not affect viability 92 
(Supplementary Fig. 3), resulted in the detection of typhoid toxin both in the 93 
supernatants (Fig. 1b) and on the bacterial cells (Fig. 1c). The detection of the toxin in 94 
these locations was strictly dependent on TtsA function since it was not detected on S. 95 
Typhi ∆ttsA bacterial cells (Fig. 1d and 1e, Supplementary Data set 1) or supernatants 96 
(Fig. 1b) after its growth in TTIM, even though the toxin levels of expression in the ∆ttsA 97 
mutant and wild-type strains were indistinguishable (Fig. 1f). Intracellular bacteria, 98 
particularly those that like S. Typhi inhabit lysosome-related-organelles 18, are exposed 99 
to a myriad of membrane disrupting compounds such as antimicrobial peptides, or 100 
membrane active proteins such as those of the saposin or perforin families 19-21.  S. 101 
Typhi in particular, is known to colonize the gallbladder and to form biofilms in 102 
gallbladder stones 22,23, which would readily expose it to bile salts. We hypothesized that, 103 
similarly to Triton X-100, these compounds could act as stimulators of toxin release. In 104 
fact, we have previously shown that antimicrobial peptides can stimulate typhoid toxin 105 
expression 14. We therefore tested whether the addition of antimicrobial peptides or bile 106 
salts could trigger typhoid toxin release to cell-free supernatants after S. Typhi growth in 107 
TTIM. Western blot analysis indicated that addition of the antimicrobial peptides C18G, 108 
polymyxin B, or bile salts at concentrations that did not inhibit S. Typhi growth 109 
(Supplementary Fig. 3) stimulated the rapid release of up to ~20% of the total typhoid 110 
toxin pool in wild-type S. Typhi but not in its isogenic ∆ttsA mutant grown under the 111 
same conditions (Fig. 1g). We also utilized LC-MS/MS to examine the cell-free 112 
supernatants of wild type and ∆ttsA S. Typhi grown in TTIM after stimulation with the 113 
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same agonists. We found that addition of antimicrobial peptides C18G, polymyxin B, or 114 
bile salts resulted in the selective release of typhoid toxin into the cell-free supernatants 115 
of wild type bacteria as no other resident periplasmic proteins were detected by our 116 
analysis (Supplementary Data Set 6). Consistent with the Western blot analysis, typhoid 117 
toxin was not detected in cell-free supernatants of the S. Typhi ∆ttsA mutant strain under 118 
any condition. These results indicate that the TtsA-mediated translocation of typhoid 119 
toxin through the peptidoglycan (PG) layer must position the toxin at a subcellular site 120 
from where it can be subsequently released upon reception of the appropriate stimuli. 121 
 122 
TtsA mediates the transport of typhoid toxin to the trans side of the peptidoglycan 123 
layer. To characterize the subcellular compartment from which typhoid toxin is released 124 
to the extracellular space, we investigated its subcellular location in bacterial cells grown 125 
in vitro using immunofluorescence microscopy and different membrane permeabilization 126 
protocols. We found that, in contrast to wild type, typhoid toxin could not be detected on 127 
the S. Typhi ∆ttsA mutant cells even after treatment with higher concentration of Triton 128 
X-100 (1%) than that required for its release from wild-type bacteria (0.1 %) (Fig. 2a and 129 
2b). Under these conditions, the inner-membrane-anchored periplasmic protein DsbD 130 
epitope tagged at its periplasmic C-terminus 24 could not be detected by antibody 131 
staining in wild-type S. Typhi (Fig. 2a and 2b). This observation indicates that in the 132 
absence of TtsA, typhoid toxin, like DsbD, is located on the cis side of the PG layer 133 
inaccessible to antibody molecules. Consistent with this hypothesis, disruption of the PG 134 
layer by lysozyme treatment resulted in the detection on the bacterial cell of both, 135 
typhoid toxin and the inner-membrane anchored periplasmic protein DsbD, in the 136 
presence or in the absence of TtsA (Fig. 2a and 2b and Supplementary data set 2). 137 
These experimental conditions did not result in the detection of a cytoplasmic control 138 
protein (Fig. 2a and 2b and Supplementary Fig. 4) indicating that although the treatment 139 
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disrupted the outer membrane and PG layer, it did not allow access of the antibody to 140 
the bacterial cytoplasm, a measure of an intact inner membrane. These results indicate 141 
that TtsA allows the translocation of typhoid toxin through a fenestration of the PG to 142 
reach the trans side of the PG layer, a location where it becomes accessible to antibody 143 
molecules after a minor disruption of the outer membrane. In the absence of TtsA, 144 
typhoid toxin remains in the cis side of the PG layer where it is inaccessible to antibody 145 
molecules even after disruption of the outer membrane. To further probe this hypothesis, 146 
we carried out proteinase K susceptibility studies after different permeabilization 147 
protocols. We found that although proteinase K treatment of wild-type S. Typhi cells 148 
readily eliminated the detection of typhoid toxin, it did not affect the detection of the inner 149 
membrane-anchored periplasmic control protein DsbD or typhoid toxin in a ∆ttsA mutant 150 
S. Typhi (Fig. 2c and Supplementary data set 2).  However, disruption of the continuity 151 
of the PG layer by lysozyme pre-treatment completely abolished the detection of DsbD 152 
and typhoid toxin in both wild-type or ∆ttsA S. Typhi after addition of proteinase K (Fig. 153 
2d and Supplementary data set 2). Taken together, these results demonstrate that: 1) 154 
typhoid toxin resides in a compartment different from the compartment harboring the 155 
canonical periplasmic protein DsbD; 2) these compartments are separated by the PG 156 
layer; and 3) typhoid toxin resides in the trans side of the PG layer. Notably, in wild-type 157 
bacteria, proteinase K treatment without addition of lysozyme resulted in the removal of 158 
the entire population of typhoid toxin (Fig. 2e and Supplementary data set 2) indicating 159 
that the bulk of typhoid toxin molecules are located on the trans side of the PG layer, 160 
thus arguing that the TtsA-dependent toxin translocation process must be highly 161 
efficient. 162 
 163 
Typhoid toxin and TtsA localize to the bacterial poles.  During execution of these 164 
experiments, we noticed that typhoid toxin was preferentially detected at the bacterial 165 
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poles. We therefore quantified the distribution of the typhoid toxin components CdtB and 166 
PltB using immunofluorescence microscopy and image analysis. We found a strong 167 
polar localization for both proteins (Fig. 3a, Supplementary Fig. 5 and Supplementary 168 
data set 3). Furthermore, the polar localization was also readily observed in intracellular 169 
bacteria after infection of cultured epithelial cells (Fig. 3b, Supplementary Fig. 5 and 170 
Supplementary data set 3). The localization of typhoid toxin at the bacterial poles was 171 
confirmed by live imaging of GFP-tagged CdtB (Supplementary Fig. 6) and by 172 
immunoelectron microscopy both in bacteria grown in vitro in TTIM, as well as in 173 
bacteria within cultured epithelial cells after bacterial infection (Supplementary Fig. 7). 174 
We also examined the localization of TtsA both after growth in vitro and after bacterial 175 
infection in vivo.  We found that, like typhoid toxin, TtsA is also localized at the bacterial 176 
poles (Fig. 3a and 3b and Supplementary data set 3). These results indicate that typhoid 177 
toxin is likely translocated at the bacterial poles and that the activity of TtsA may be 178 
selectively exerted at a discrete site of the bacterial envelope.  179 
 180 
TtsA exerts its activity at the bacterial poles.  The polar localization of TtsA 181 
suggested that its activity might be exerted at the bacterial poles, in which case TtsA-182 
dependent PG remodeling should be detectable at these sites. To test this hypothesis 183 
we labeled the S. Typhi PG using an alkyne-modified D-alanine and an azide-containing 184 
fluorophore that can be linked by click chemistry 25. The PG structure features linear 185 
glycan strands made up of alternating N-acetylglucosamine (GlcNac) and N-186 
acetylmuramic acid (MurNac) residues linked by β-(1, 4) glycosidic bonds 26-28. These 187 
sugar backbone strands are connected by short peptides, which contain D-alanine 188 
residues. Consequently, metabolic incorporation of alkyne-modified D-alanine and its 189 
subsequent linking to an azide-containing fluorophore can be used to label remodeling 190 
PG 25,29,30. To ascertain that this PG labeling strategy could be used in S. Typhi, we grew 191 
 9
the bacteria in rich medium (LB broth) to exponential growth phase, followed by 5 or 60 192 
minutes growth in the presence of alkyne-D-alanine. We found that after a short (5 min) 193 
labeling pulse, labeled PG could be readily visualized at the cell division septum, its 194 
place of enhanced synthesis during exponential growth (Supplementary Fig. 8). As 195 
expected, a long (60 min) labeling pulse led to PG labeling all around the entire body of 196 
the bacteria (Supplementary Fig. 8). These results confirmed that this approach can be 197 
used to detect PG remodeling in S. Typhi, and therefore we used it to label PG after 198 
growth to stationary phase in TTIM, conditions that lead to TtsA and typhoid toxin 199 
expression. We found that, in contrast to what we observed after logarithmic growth in 200 
LB broth, when S. Typhi was grown to stationary phase in TTIM for 24 hs followed by an 201 
additional 4 hs of growth in the presence of alkyne-D-alanine, PG labeling was 202 
preponderantly detected at the poles of the bacteria (Fig. 4a, Supplementary Fig. 9, and 203 
Supplementary data set 4). Importantly, in the S. Typhi ∆ttsA mutant we observed 204 
markedly reduced labeling, which was distributed throughout the body of the bacteria 205 
rather than concentrated at the poles (Fig. 4a, Supplementary Fig. 9, and 206 
Supplementary data set 4). These results indicate that when S. Typhi is grown under 207 
conditions that lead to typhoid toxin expression, TtsA exerts its activity on PG located at 208 
the bacterial poles, resulting in PG remodeling likely as a result of the repair process that 209 
may follow its PG hydrolytic action.  210 
To gain insight into the mechanisms that may restrict the activity of TtsA at the 211 
poles we examined the fate of TtsA and peptidoglycan remodeling at the poles of 212 
bacteria that had been allowed to re-enter the cell cycle (conditions not permissive for 213 
TtsA activity), after growth to stationary phase (conditions permissive for TtsA 214 
expression and activity). We grew S. Typhi to stationary phase in TTIM and labeled the 215 
bacterial cultures with alkyne-D-alanine as described above. After 4 hs of growth in the 216 
presence of alkyne-D-alanine, we split the cultures and added either casamino acids, 217 
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which stimulate re-entry of the bacteria into the logarithmic phase of growth (see 218 
Supplementary Fig. 10), or eluent (mock) and further grew the cultures for various times 219 
(always in the presence of alkyne-D-alanine). We found that, in the presence of 220 
casamino acids the alkyne-D-alanine-dependent fluorescent signal at the poles was 221 
significantly diminished over time (Fig. 4b and Supplementary data set 4), even though 222 
under these conditions TtsA remained at the poles (Fig. 4d, Supplementary Fig. 11, and 223 
Supplementary data set 4). In contrast, in cultures without casamino acids, the 224 
fluorescent signal was readily detected at the poles (Fig. 4c). Taken together these 225 
results indicate that the presence of TtsA at the bacterial poles is not sufficient to induce 226 
polar PG remodeling and that a specific PG structure may be required for TtsA to exert 227 
its activity.  228 
 229 
YcbB-dependent peptidoglycan editing is required for typhoid toxin translocation 230 
across the bacterial envelope. The glycan strands that form the PG layer are 231 
connected by short 6-9 amino acid peptides to maintain the rigidity of the cell wall 26-28. 232 
The peptides contain L- and D-amino acids and in Gram-negative bacterial species like 233 
S. Typhi, the nascent peptide sequence is L-Ala-D-Glu-m-Dap (i. e. meso-234 
diaminopimelic acid)-D-Ala-D-Ala. Some of the peptides are crosslinked by 235 
transpeptidase enzymes, among which the so-called penicillin-binding proteins (PBPs) 236 
produce the most commonly observed cross-links between the carboxyl group of D-Ala 237 
at position 4 of one peptide to the ε-amino group of the m-Dap residue at position 3 of 238 
another (the so called 4–3 or DD-cross-links) 31. However, other minor cross-links are 239 
observed between two m-Dap residues of adjacent stem peptides (the so called 3-3 or 240 
LD cross-links), which in exponentially growing cells amount to only ~2% of all cross 241 
links but that in stationary phase, or in intracellular bacteria can account for as much as 242 
~20% of all cross-links 31-33. These cross-links are catalyzed by LD-transpeptidases, 243 
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which are structurally and functionally unrelated to PBPs 34,35. Unlike DD-244 
transpeptidases, LD-transpeptidases are non-essential for growth, which is consistent 245 
with the notion that they are responsible for modifying only a minor proportion of the PG 246 
molecules. The activities of PG hydrolases are often dependent on specific modifications 247 
of the PG chain imparted by various enzymes including transpeptidases 36. Our 248 
observation that the TtsA activity may depend on specific structural features of the PG 249 
subunits prompted us to investigate the potential contribution of LD-transpeptidases to 250 
typhoid toxin secretion. S. Typhi encodes four LD-transpeptidases: YbiS, ErfK, YcfS, 251 
which cross-link the PG to Braun's lipoprotein 34, and YcbB, which  catalyzes the 252 
formation of a direct link between two m-DAP residues 35. A homolog of ynhG, which 253 
encodes another enzyme with this activity, is a pseudogene in S. Typhi. We found that 254 
introduction of deletion mutations in ybiS, erfK, ycfS, alone or in combination, had no 255 
effect on typhoid toxin secretion (Fig. 5a, 5b, and Supplementary data set 5). However, 256 
introduction of a deletion in ycbB completely abolished typhoid toxin secretion, both in 257 
vitro (Fig. 5c and Supplementary data set 5) and after bacterial infection of cultured cells 258 
(Fig. 5d and Supplementary data set 5), although the introduction of any of the mutations 259 
did not affect typhoid toxin expression (Supplementary Fig. 12). The contribution of YcbB 260 
to typhoid toxin secretion was strictly dependent on its catalytic activity since expression 261 
of the catalytic mutant YcbBC528A was unable to complement a ∆ycbB S. Typhi mutant 262 
strain (Fig. 5c and 5d and Supplementary data set 5).  These results suggest that YcbB 263 
imparts localized PG modifications that are essential for TtsA activity. Consistent with 264 
this hypothesis, we found that the TtsA-dependent polar remodeling of the peptidoglycan 265 
was strictly dependent on YcbB (Fig. 5E, Supplementary Fig. 13, and supplementary 266 
data set 5), and that YcbB itself was enriched at the bacterial poles (Fig. 5f and 267 
Supplementary data set 5).   268 
 269 
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YcbB-edited peptidoglycan is a substrate for TtsA activity. To further explore the 270 
mechanisms for TtsA specificity, we compared the PG structures of wild-type and ∆ycbB 271 
S. Typhi strains grown in TTIM, which is permissive for TtsA activity. We found that while 272 
the PG of wild-type S. Typhi grown under these conditions exhibited a significant amount 273 
of tripeptides and 3-3 (mDAP-mDAP) cross-links, these cross-links were not detect in 274 
the ∆ycbB mutant (Fig. 6a and Table S1). Consistent with these observations we found 275 
that expression of a form of TtsA containing a Sec-dependent secretion signal (ssTtsA) 276 
in S. Typhi (for its efficient delivery into the periplasm) led to a significant reduction in 277 
CFU (presumably due to deleterious effects affecting viability or growth) after growth in 278 
TTIM, which leads to a PG structure containing significant amount of 3-3 cross-links (Fig. 279 
6b and Supplementary Fig. 14). In contrast, such an effect was not observed when 280 
ssTtsA was expressed in a ∆ycbB mutant grown under the same conditions, or in wild-281 
type S. Typhi grown in LB broth (Fig. 6b and Supplementary Fig. 14), a condition that 282 
leads to a reduced amount of 3-3 cross-links 33, indicating that TtsA cannot exert its toxic 283 
effect in PG that is not rich in 3-3 crosslinks.  We then tested the in vitro enzymatic 284 
activity of purified TtsA on PG obtained from wild-type or ∆ycbB S. Typhi strains grown 285 
under different conditions and using two different assays. We found that while TtsA was 286 
able to hydrolyze S. Typhi PG from wild-type bacteria grown in TTIM, no TtsA-mediated 287 
hydrolysis was detected in PG from wild-type bacteria grown in LB to logarithmic phase 288 
(conditions incompatible with TtsA activity), or in PG from the ∆ycbB mutant grown under 289 
any condition (Fig. 6c and 6d), while lysozyme was able to hydrolyze all PG preparations 290 
(Fig. 6c and 6d). Taken together these results indicate that the TtsA activity is strictly 291 
exerted on YcbB-edited PG at the bacterial poles and that it most likely requires 3-3 292 
cross-linked PG to exert its hydrolytic activity.  293 
 294 
Discussion 295 
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 296 
Gram-negative bacteria have evolved multiple secretion mechanisms of varying 297 
complexities to transport proteins across the bacterial envelope 1-4. While some protein 298 
secretion machines can move their substrates through all the layers of the bacterial 299 
envelope in one step, others operate by engaging the substrates in the bacterial 300 
periplasm after their translocation by the Sec machinery.  We have described here a 301 
novel mechanism of protein translocation across the bacterial envelope responsible for 302 
the export of S. Typhi’s typhoid toxin (Fig. 7). Through this mechanism the individual 303 
subunits of the toxin are first secreted to the periplasm by the Sec machinery, where 304 
they assemble into the holotoxin complex. The holotoxin is then translocated across the 305 
PG layer to a compartment that we have found to be on the trans side of the PG layer. 306 
We propose that translocation of the toxin to this compartment positions it so that it can 307 
be released in the presence of specific agonists with the capacity to infringe minor 308 
disruption to the bacterial outer membrane. The specific nature of such agonist(s) is not 309 
known and may vary depending on the specific environments in which S. Typhi resides 310 
during infection. However, we have shown here that sub-inhibitory amounts of 311 
antimicrobial peptides or bile salts, which are readily encountered by S. Typhi during 312 
infection, are capable of efficiently triggering the release of the toxin. We have also 313 
recently shown that antimicrobial peptides are able to stimulate typhoid toxin expression 314 
14. Therefore, it is likely that antimicrobial peptides may be functionally relevant triggers 315 
of typhoid toxin release during S. Typhi infection. Of note, it has been reported that the 316 
release of a Zymomonas mobilis extracellular levansucrase, a process that depends on 317 
ZlyS 37,38, a homolog of TtsA, can be also stimulated by the addition of membrane active 318 
compounds 39.   319 
We demonstrated that typhoid toxin translocation occurs at the bacterial poles 320 
and depends on the activity of a specialized muramidase, TtsA, which is also located at 321 
 14
the bacterial poles. We found that the activity of TtsA requires the specific edition of 322 
peptidoglycan by the LD-transpeptidase YcbB, which cross-links two meso-Dap residues 323 
of adjacent stem peptides, thus introducing the so-called 3-3 (or LD) cross-links. 324 
Consistent with this observation, no typhoid toxin secretion or translocation to the trans 325 
side of the PG layer was observed in the absence of YcbB.  This is remarkable in that it 326 
has been reported that, at least in E. coli, the vast majority (up to 98%) of the PG 327 
crosslinks are between D-Ala and meso-Dap, the so-called 4-3 (or DD) crosslinks. 328 
However, these observations have been made with bacteria grown exponentially in rich 329 
medium, conditions that differ substantially from those encountered by intracellular 330 
bacteria (or bacteria grown in TTIM medium). In fact, there is evidence suggesting that 331 
the PG structure of intracellularly localized Salmonella may differ from that of bacteria 332 
grown exponentially in LB broth 33,40. Our results also suggest that the PG structure at 333 
the poles in bacteria grown under TTIM conditions may differ from the structure 334 
elsewhere in the bacterial body. The specialized location of typhoid toxin in the trans 335 
side of the PG at the bacterial poles also raises the intriguing possibility that in some 336 
specific environments such as the Salmonella containing vacuole the bacterial envelope 337 
itself, and in particular the architecture of the periplasmic space, may be distinct. Most 338 
knowledge about bacterial physiology or the architecture of its envelope is largely 339 
derived from studies of bacteria grown in artificial rich media. However, throughout their 340 
entire life cycle bacterial pathogens inhabit environments that differ drastically from 341 
those of the media routinely used in the laboratory to study their physiology.  342 
Consequently, more studies are required to understand the composition and architecture 343 
of the bacterial envelope under environmental conditions that more closely mimic those 344 
encountered by bacterial pathogens. 345 
The protein export mechanism described here differs significantly in its 346 
evolutionary design from other two-step protein secretion systems that mediate the 347 
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transport of Sec-translocated substrates 2-4. Indeed, all two-step protein secretion 348 
systems known today engage their substrates in what would be considered the cis side 349 
of the periplasmic space and utilize various specific outer-membrane protein channels to 350 
move their substrates through the outer membrane. It is intriguing that all the necessary 351 
elements to build the different secretion machines are always encoded within a common 352 
gene cluster, which sometimes although not always, also encodes the cognate secretion 353 
substrates. In contrast, other than ttsA, no other genes required for typhoid toxin 354 
secretion are present within the pathogenicity islet that harbors ttsA and the typhoid toxin 355 
genes.  Furthermore, despite close scrutiny, we have been unable to identify additional 356 
S. Typhi genes required for typhoid toxin secretion. Periplasmic proteins can be released 357 
to the extracellular space in outer membrane vesicles (OMVs) that are shed from 358 
bacterial cells 41,42. However, we have been unable to detect outer membrane vesicles 359 
containing typhoid toxin in S. Typhi grown under the conditions used in these studies or 360 
in intracellularly localized S. Typhi.  Furthermore, in infected cells, the packaging of 361 
typhoid toxin into vesicle carrier intermediates requires the interaction of PltB with a 362 
glycan receptor on the luminal side of the membrane of the Salmonella-containing 363 
vacuole (SCV) 15.  The topology of potential toxin containing OMVs would therefore be 364 
incompatible with this packaging mechanism. Consequently, it is unlikely that OMVs play 365 
a role in the release of typhoid toxin from S. Typhi cells.  366 
Phylogenetic and genetic analyses 16 indicate that TtsA appears to be a recent 367 
exaptation of related enzymes that are utilized by bacteriophages to exit from infected 368 
bacterial cells 43. Given the presence of homologous muramidases encoded in close 369 
proximity to bacterial toxins or large extracellular enzymes in other bacterial genomes 370 
16,37,38,44, we predict that this novel protein secretion mechanism is likely to be conserved 371 
in other bacteria. We hypothesize that this recently evolved export system provide 372 
bacterial pathogens with the unique advantage of releasing pre-synthesized toxins upon 373 
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the reception of environmental cues (e. g. antimicrobial peptides) whose presence itself 374 
may define the very specific environment in which the toxin must exert its function.  375 
 376 
Methods 377 
 378 
Bacterial strains and plasmids. The bacterial strains and plasmids used in this study 379 
are listed in Table S2. All S. Typhi strains are derived from the clinical isolate ISP2825 380 
45. All in frame deletions or insertions into the S. Typhi chromosome were generated by 381 
standard recombinant DNA and allelic exchange procedures using the E. coli β-382 
2163 ∆nic35 as the conjugative donor strain 46 and the R6K-derived suicide vector 383 
pSB890 as previously described 47. For S. Typhi ∆ttsA complementation studies, we 384 
used plasmid pSB3783, which encodes an arabinose-inducible promoter and is derived 385 
from plasmid pBAD24 48. For TtsA expression for protein purification, we used the 386 
expression plasmid pET28b (Invitrogen) in E. coli strain BL21. All plasmids used in this 387 
study were constructed using the Gibson assembly cloning strategy 49. All generated 388 
plasmids and strains used in this study have been verified by nucleotide sequencing. 389 
 390 
Bacterial and eukaryotic cell culture. S. Typhi strains were routinely cultured in L-391 
broth (LB) on a rotation wheel at 37°C. For in vitro typhoid toxin secretion assays, 392 
bacteria were sub-cultured in a chemically defined medium, which induces typhoid toxin 393 
expression and therefore is referred to as TTIM for typhoid toxin induction medium. This 394 
defined medium was adapted from previous studies 14,17 and its composition is as 395 
follows: K2SO4 (0.5 mM), KH2PO4 (1 mM), (NH4)2SO4 (7.5 mM), Tris Base (50mM), Bis 396 
Tris (50 mM), casamino acids (0.1 %), KCL (5 mM), cysteine (50 µg/ml), tryptophan (50 397 
µg/ml), glycerol (32.5 mM) and magnesium (15 µM). For host cell infection assays, 398 
bacteria were sub-cultured in LB containing 0.3 M NaCl, to stimulate expression of the 399 
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SPI-1 type III secretion system 50. When appropriate, ampicillin (100 µg/ml), Kanamycin 400 
(50 µg/ml) and tetracycline (10 µg/ml) were added to the bacterial cultures. The Henle-401 
407 human intestinal epithelial cells were grown in Dulbecco's modified Eagle medium 402 
(DMEM, Gibco) supplemented with 10 % bovine calf serum (BCS, Gemini Bioproducts) 403 
at 37°C with 5 % CO2 in a humidified incubator. 404 
 405 
In vitro typhoid toxin expression and secretion assay. To detect typhoid toxin and 406 
TtsA expression in S. Typhi strains carrying chromosomally encoded 3xFLAG-epitope-407 
tagged versions of CdtB (a typhoid toxin subunit) or TtsA, the different strains were 408 
grown overnight in LB, washed twice with 1 x PBS (without MgCl supplement, Difco) and 409 
sub-cultured in TTIM after a 1:50 dilution. At the indicated time points, an equal number 410 
of bacteria (standardized by CFU) were harvested and bacterial pellets were 411 
resuspended in Laemmli buffer and boiled for 5 minutes. The expression profile of TtsA 412 
and CdtB was determined by Western blot analysis using a mouse monoclonal antibody 413 
directed to the FLAG-epitope (Invitrogen). As a loading control, samples were analyzed 414 
on a separate Western blot with a polyclonal rabbit antibody directed to RecA. 415 
To detect secreted typhoid toxin in bacterial supernatants, S. Typhi wild type and 416 
the isogenic ∆ttsA mutant strains, both with chromosomally-encoded 3xFLAG-tagged 417 
CdtB, were grown 24 hs in TTIM to induce typhoid toxin and TtsA expression. Bacterial 418 
cultures were then mock treated for 30 min, or treated with Triton X-100 (0.1 %) (Sigma-419 
Aldrich) for 15 min, bile salts (0.05 %) (Sigma-Aldrich) for 15 min, polymyxin B (0.1 420 
µg/ml) (Sigma-Aldrich) for 10 min, or C18G antimicrobial peptide (2.5µg/ml) (AnaSpec 421 
Inc.) for 30 min. Bacterial pellets and trichloroacetic acid (TCA)-precipitated 422 
supernatants (overnight at 4°C) were resuspended in Laemmli buffer and boiled for 5 423 
minutes. The presence of typhoid toxin (CdtB subunit) in the supernatants and in the 424 
pellets was determined by Western blot analyses as indicated above. Cytoplasmic RecA 425 
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served as a negative control for cell lyses in the supernatant analyses and as loading 426 
controls for the whole cell lysates. Detection of secreted proteins in the bacterial 427 
supernatants by LC-MS/MS analysis after TCA precipitation (overnight at 4°C) was 428 
carried out as previously described 51. 429 
      430 
Immunofluorescence microscopy of bacteria grown in vitro. The indicated S. Typhi 431 
strains were grown in TTIM for 24 hs and bacteria were then washed with PBS and fixed 432 
using 4 % paraformaldehyde (PFA) for 15 min. No fixation or other treatments were 433 
performed for the visualization of S. Typhi strains chromosomally encoding CdtB-sfGFP 434 
and plasmid-born mCherry. When indicated, fixed bacteria were treated with lysozyme 435 
(Sigma Aldrich) (50 µg/ml) for 20 min in Tris-buffer (pH 8) at 37°C. Bacteria were then 436 
washed and mounted on poly-(D)-lysine (Sigma-Aldrich) coated glass coverslips. The 437 
coverslips with attached bacteria were washed with PBS and, if applicable, incubated 438 
with 1 % Triton X-100 in PBS for 30 min, washed again, and incubated overnight at 4°C 439 
with primary anti-FLAG M2 mouse monoclonal antibody (Sigma) (1:10,000) and anti-440 
Salmonella O poly A-1 & Vi rabbit antiserum (Becton, Dickinson & Co.) (1:10,000) in 441 
PBS, containing 1 % bovine serum albumin (BSA) and 0.01 % Triton X-100. After 442 
removal of the primary antibody, the coverslips were washed 6 times with 1 x PBS and 443 
incubated with secondary Alexa-Fluor 488-conjugated anti-mouse and Alexa-Fluor 594-444 
conjugated anti-rabbit (Invitrogen) (1:2,000) antibodies in PBS, containing 1% bovine 445 
serum albumin (BSA) and 0.01 % Triton X-100 for 60 min at RT protected from light. 446 
Mounted samples (ProLong Gold antifade, Molecular Probes) were visualized in an 447 
Eclipse TE2000-U (Nikon) microscope equipped with an Andor Zyla 5.5 sCMOS camera 448 
driven by Micromanager software (https://www.micro-manager.org). 449 
 450 
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S. Typhi cultured cell infection assays. The different S. Typhi strains were grown 451 
overnight and then sub-cultured (1:50) in fresh LB containing 0.3 M NaCl, to stimulate 452 
expression of the SPI-1 type III secretion system 50. When bacteria reached an OD600 of 453 
0.9, cultured epithelial Henle-407 cells were infected for 1 hour in Hank`s balanced salt 454 
solution (HBSS, Gibco) at a multiplicity of infection (MOI) of 30. Cells were then washed 455 
twice with HBSS and further incubated with culture medium supplemented with 456 
gentamicin (100 µg/ml) for 1 hr to kill remaining extracellular bacteria, and further 457 
incubated in culture medium containing gentamicin (5 µg/ml) to avoid cycles of 458 
reinfection. 459 
  460 
Immunofluorescence microscopy of infected cultured epithelial cells. Twenty-four 461 
hours after infection with the indicated S. Typhi strains, Henle-407 cells cultured on glass 462 
coverslips were rinsed with PBS and fixed with 4% paraformaldehyde for 15 min at room 463 
temperature. No fixation or other treatments were performed prior to the visualization of 464 
cultured cells infected with S. Typhi strains expressing CdtB-sfGFP and mCherry. 465 
Samples were incubated in 50 mM NH4Cl in PBS for 10 min and subsequently blocked 466 
in 1% bovine serum albumin and 0.1 % Triton X-100 in PBS for 30 minutes. Coverslips 467 
were washed and incubated overnight at 4°C with primary anti-FLAG M2 mouse 468 
monoclonal antibody (Sigma) (1:10,000) and anti-Salmonella O poly A-1 & Vi rabbit 469 
antiserum (Becton, Dickinson & Co.) (1:10,000) in PBS, containing 1 % bovine serum 470 
albumin (BSA) and 0.01 % Triton X-100. Coverslips were then washed 6 times with 1 x 471 
PBS and incubated for 60 min at RT (protected from light) with secondary Alexa-Fluor 472 
488-conjugated anti-mouse and Alexa-Fluor 594-conjugated anti-rabbit (Invitrogen) 473 
(1:2,000) antibodies and 0.5 µg/ml 4´,6-diamidino-2-phenylindole (DAPI) in PBS, 474 
containing 1 % bovine serum albumin (BSA) and 0.01 % Triton X-100. Mounted samples 475 
(ProLong Gold antifade, Molecular Probes) were visualized in an Eclipse TE2000-U 476 
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(Nikon) microscope equipped with an Andor Zyla 5.5 sCMOS camera driven by 477 
Micromanager software (https://www.micro-manager.org). 478 
  479 
Quantification of fluorescence-positive bacteria after growth in vitro and within 480 
infected cells. Bacterial associated fluorescence signals from FLAG-tagged CdtB (to 481 
visualize typhoid toxin), DsbD, or SlyA were quantified by fluorescence microscopy using 482 
the open source software ImageJ with MicrobeJ plug-in (http://rsbweb.nih.gov/ij/) 52. 483 
Images were captured from randomly selected fields in both, the red (LPS signal to 484 
identify all bacterial cells) and green (to identify CdtB- ,DsbD-, or SlyA-positive bacteria) 485 
channels. The relative number of bacteria positive for CdtB, DsbD, or SlyA was then 486 
determined. For each bacterial strain and/or condition examined, 30 images were 487 
analyzed, from which 100 bacteria were automatically selected by the software for 488 
quantification (totaling 3,000 bacteria in three independent experiments. 489 
 490 
Quantification of typhoid toxin-associated transport intermediates. The typhoid 491 
toxin vesicular transport intermediates were quantified by fluorescent microscopy using 492 
the open source software ImageJ (http://rsbweb.nih.gov/ij/) as described previously 15.  493 
Briefly, images were captured from randomly-selected fields. Images from the LPS stain 494 
were used to identify the area corresponding to the bacterial cell body and this area was 495 
used to obtain the bacterial-associated typhoid toxin fluorescence signal, which was 496 
substracted from the typhoid toxin-associated fluorescence. The remaining fluorescence 497 
was considered to be associated with typhoid toxin carrier intermediates. Finally, the 498 
intensity of fluorescence associated with toxin carriers in each field was normalized 499 
using the fluorescence-associated with typhoid toxin in bacterial cells in the same field. 500 
 501 
 21
Immunoelectron microscopy. A S. Typhi strain carrying chromosomally-encoded 502 
encoded FLAG-tagged CdtB was grown in TTMI for 24 hs, fixed with 4 % PFA, washed, 503 
and bacterial pellets were quickly frozen in liquid nitrogen. Alternatively, the same 504 
bacterial strain was grown in LB as indicated above to infect Henle 407 human epithelial 505 
cells, and 24 hs after infection, infected cells were fixed with 4% PFA, washed, and 506 
infected cell pellets were quickly frozen in liquid nitrogen. Samples were then processed 507 
for immunoelectron microscopy as previously described 53 using a mouse primary 508 
antibody (1:500), directed to the FLAG-epitopes and a secondary immunogold (8 nm)-509 
labeled anti-mouse antibody (1:150). 510 
  511 
Proteinase K protection assay. S. Typhi wild-type and ∆ttsA mutant strains expressing 512 
chromosomally encoded FLAG-tagged CdtB or DsbD were grown in TTIM for 24 hs, 513 
washed with 1 x PBS and subjected to two alternative procedures:  514 
Procedure 1: Bacterial cells were treated with proteinase K (100 µg/ml) at 37°C for 30 515 
min in Tris buffer (pH 8.0), washed thoroughly 4 times with 1 x PBS to remove any 516 
remaining proteinase K, fixed with 4 % PFA for 15 min at RT, and treated with lysozyme 517 
(50 µg/ml) for 20 min at 37°C in Tris buffer (pH 8.0). 518 
Procedure 2: Bacterial cells were fixed with 4% PFA for 15 min at RT, washed twice with 519 
1 x PBS, followed by mock treatment or treatment with lysozyme (50 µg/ml) for 20 min at 520 
37°C in Tris buffer (pH 8.0), washed twice with 1 x PBS, followed by mock treatment or 521 
treatment with proteinase K (100 µg/ml) for 30 min at 37°C in Tris buffer pH 8.0 522 
All samples were subsequently treated with 0.3 % Triton X-100 for 30 min at RT 523 
and mounted on (D)-polylysine coated coverslips. Fluorescence microscopy and 524 
quantifications of tagged-protein-associated fluorescence signals (green) normalized to 525 
the LPS signals (red) were performed as described above. 526 
  527 
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Fluorescence labeling of peptidoglycan. S. Typhi wild type, ∆ttsA and ∆ycbB mutant 528 
strains were grown in TTIM for 24 hs, and subsequently incubated in TTIM containing 529 
alkyne-D-alanine (2 mM) (Boao Pharma, Boston) for 4 hs. To analyze peptidoglycan 530 
remodeling in bacteria that had been allowed to re-enter the cell cycle after growth to 531 
stationary phase, S. Typhi strains were grown to stationary phase in TTIM and labeled 532 
with alkyne-D-alanine as described above. Bacterial cultures were then split, casamino 533 
acids or eluent were added, and cultures were further grown for the indicated times 534 
(always in the presence of alkyne-D-alanine). In all cases, after the various growth 535 
conditions bacteria were washed with PBS and fixed for 15 min in 4% paraformaldehyde 536 
(PFA) at room temperature. Fixed bacteria were resuspended in Click-iT Cell Reaction 537 
Buffer (Invitrogen) and copper-catalyzed click-chemistry was performed in the dark at 538 
room temperature for 30 min using the Click-iT Cell Reaction Kit (Invitrogen) with 10 µM 539 
azido-Alexa-Fluoro488 fluorophore (Invitrogen). Bacteria were then washed three times 540 
and attached to poly-(D) lysine coated coverslips. If applicable bacterial cells were 541 
counterstained for LPS (red) with primary anti-Salmonella O poly A-1 & Vi rabbit 542 
antiserum (Becton, Dickinson & Co.) (1:10,000) and secondary anti-rabbit Alexa-543 
Fluor594 (Invitrogen) (1:2,000) antibody.  544 
 545 
Fluorescence distribution analyses . The line scan analysis of the distribution of 546 
fluorescence signal intensities of labeled peptidoglycan or stained bacteria along the 547 
medial axes of the bacterial cell bodies was carried out using the MicrobeJ plug-in 52 of 548 
ImageJ (https://imagej.nih.gov/ij/index.html) software. Random fluorescence microscopy 549 
images were obtained and bacterial cells were defined as regions of interest (ROI) by 550 
using LPS (red) counterstaining. The center within each ROI was identified and 26 551 
measuring points along the medial axes of the bacteria from the center (0) to each of the 552 
poles (1.0) were automatically selected on the peptidoglycan or labeled antibody 553 
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fluorescence channels (green). For the peptidoglycan-associated fluorescence 554 
distribution analysis, the fluorescence signal associated with non-TtsA-dependent PG 555 
labeling was substracted . 556 
 557 
TtsA protein purification. The coding sequence for ttsA was amplified from S. Typhi 558 
strain ISP2825 and cloned by Gibson cloning strategy 49 into the expression vector 559 
pET28a+ (Novagen) resulting in N-terminal his-epitope tagged TtsA. Expression and 560 
purification of TtsAWT and catalytic mutant TtsAE14A were carried out as previously 561 
described 11. Escherichia coli strain BL21 carrying the different plasmids were grown in 562 
LB containing kanamycin (50 µg/ml) to an OD600 nm of 0.6–0.7 at 37 °C. Expression of 563 
TtsA was subsequently induced by the addition of 0.5 mM IPTG, and induced cultures 564 
were incubated overnight at 25°C. Bacterial cells were pelleted by centrifugation, 565 
resuspended in lysis buffer [Tris-HCl (150 mM, pH 8.0), NaCl (100 mM), imidazol (10 566 
mM), lysozyme (100 µg/ml), DNAse (100 µg/ml), saturated PMSF] and lysed with a 567 
French press. Lysates were subsequently pelleted (20,000g 1h, 4°C), and affinity-568 
purified using a Nickel-resin (Qiagen) column. The eluates were diluted in 20 mM Tris-569 
HCl, pH 8.0 buffer and loaded onto a Hi Trap Q ion-exchange column. Fractions from the 570 
ion-exchange chromatography were monitored on SDS–PAGE, concentrated, and 571 
further purified by using a Superdex 200 column. Final fractions were examined for 572 
purity on a 12 % SDS–PAGE. 573 
 574 
Peptidoglycan hydrolysis assays. S. Typhi wild-type and ∆ycbB mutant strains were 575 
grown in TTIM for 24 hs or, when indicated, in LB to logarithmic growth phase (OD600 576 
0.5), and peptidoglycan was then isolated as previously described 54. Purified 577 
peptidoglycan preparations were resuspended in MilliQ water containing 0.01 % NaN3 578 
and stored at 4°C until their use in the different assays. Muramidase activity of purified 579 
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TtsA was detected by in gel digestion (zymographic assay) or by a turbidimetry 580 
assay. For the zymogram assay, purified TtsA (10 µg), its catalytic mutant TtsAE14A (10 581 
µg), or lysozyme (10 µg) were separated on a 12 % low SDS (0.01 %) polyacrylamide 582 
gels containing 0.1 % (w/v) purified S. Typhi peptidoglycan. Protein samples were not 583 
boiled and the sample loading buffer contained 0.1 % coomassie blue G-250 with 150 584 
mM 6-aminocaproic acid (ACA) but no SDS. Following electrophoresis, the gels were 585 
split in half. One half was used as protein loading control and was stained with 586 
coomassie (0.5 %). The other half was used for the zymogram assay. In this case the 587 
gels were rinsed and soaked in water twice for 5 min at room temperature, incubated 588 
twice for 1 hr in washing buffer [100 mM Tris–HCl (pH 8.0), 1% (v/v) Triton X-100] at 589 
room temperature with gentle agitation, rinsed and soaked twice with water for 5 min, 590 
and subsequently incubated overnight at 37°C in enzyme activity buffer [20 mM Tris-591 
HCL (pH6.8) and 50 mM NaCl] with gentle agitation. Gels were stained for peptidoglycan 592 
with 0.1% (w/v) methylene blue in 0.01% (w/v) KOH, and after de-staining with water, 593 
the unstained bands due to local degradation of peptidoglycan appeared as a clear zone 594 
in a blue background of stained peptidoglycan. The turbidimetric assay was performed 595 
with the same highly purified peptidoglycan preparation as used for the zymographic 596 
assay. Isolated peptidoglycan was diluted in enzyme activity buffer [20 mM Tris-HCL 597 
(pH6.8), 50 mM NaCl] to an OD540 of ~0.175. Purified TtsA, TtsAE14A or lysozyme (5 µg 598 
of each) were added to the buffer and optical densities measurements at 540nm were 599 
performed at the indicated time points. 600 
 601 
Bacterial growth arrest assay. S. Typhi wild-type and ∆ycbB mutant strains, 602 
expressing plasmid-born TtsA containing a N-terminal Sec translocation signal sequence 603 
from DsbA under the control of an arabinose inducible promoter, were grown overnight 604 
in LB medium supplemented with 5 µg/ml tetracycline. Overnight grown bacteria were 605 
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subcultured (1:50) in TTIM or LB and grown to an OD600 of 0.3, at which point 0.001 % 606 
arabinose was added to the bacterial cultures to induce the expression of TtsA, and 607 
further incubated for 20 hs. Colony forming units (CFUs) were then determined by 608 
plating bacterial dilutions on LB agar plates. 609 
 610 
HPLC-MS analyses of isolated S. Typhi peptidoglycan. PG was isolated and 611 
analyzed according to a previously described procedure 55. 612 
 613 
  614 
 615 
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Figure legends:  786 
 787 
Figure 1. TtsA-dependent translocation and agonist-mediated release of typhoid 788 
toxin after S. Typhi growth in vitro   789 
(a) Expression of TtsA and typhoid toxin after S. Typhi in vitro growth in typhoid toxin 790 
inducing media (TTIM). Overnight cultures of S. Typhi carrying chromosomally encoded 791 
FLAG-tagged CdtB (as a surrogate for typhoid toxin) or TtsA were diluted in TTIM and 792 
the expression of TtsA and CdtB, a component of typhoid toxin, in equal number of 793 
bacterial cells was monitored over time by Western blot analysis. The amount of RecA in 794 
each sample (used as a loading control) was analyzed on a separate Western blot. (b-e) 795 
Outer membrane disruption results in the TtsA-dependent detection of typhoid toxin in 796 
the culture supernatants and on the bacterial cells. Wild-type and ∆ttsA S. Typhi carrying 797 
chromosomally-encoded FLAG-tagged CdtB were grown in TTIM for 24 hs, pelleted and 798 
washed twice with PBS, and subsequently treated with Triton X-100 (0.1 %) for 15 min. 799 
Bacterial whole cell lysates and filtered culture supernatants were then analyzed by 800 
Western blotting for the presence of CdtB and RecA (as a cell lysis and loading control) 801 
(b). Alternatively, wild-type S. Typhi was grown 24 hs in TTIM, fixed, treated with Triton 802 
X-100 (0.1%) or PBS (mock treated), and then stained with mouse anti-FLAG (to stain 803 
CdtB) (green) and rabbit anti S. Typhi LPS (to visualize bacterial cells) (red) (c). (d and 804 
e) The indicated strains grown in the same manner were fixed, treated with Triton X-100 805 
(0.1 %) and stained as indicated above. The number of bacterial cells positive for 806 
typhoid toxin-associated fluorescence signal (green) was quantified relative to the total 807 
number of bacterial cells analyzed (LPS signal, red). The average ratios of typhoid toxin 808 
positive cells vs total cells ± standard deviation from 3 independent experiments are 809 
shown. In total 30 images were collected from which 100 randomly selected bacteria per 810 
image were analyzed resulting in 3,000 bacterial cells analyzed per bacterial strain (**** 811 
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p < 0.0001, Student t Test) (Supplementary data set 1) (e). The levels of CdtB in the 812 
strains used in panel (c) were determined by Western blot analysis with antibodies to the 813 
FLAG tag and RecA (as a loading control analyzed on a separate Western blot) (f). (g) 814 
Antimicrobial peptides trigger the release of typhoid toxin to the culture supernatants. 815 
Wild-type and ∆ttsA S. Typhi strains carrying chromosomally-encoded FLAG-tagged 816 
CdtB were grown 24 hs in TTIM, pelleted and washed twice with PBS and subsequently 817 
treated with sub-inhibitory concentrations of the antimicrobial peptide C18G (2.5µg/ml) 818 
for 30 min, Polymyxin B (0.1µg/ml) for 10 min, Triton X-100 (0.1%) for 15 min, or bile 819 
salts (0.05 %) for 15 min. Bacteria were then harvested and filtered supernatants and 820 
whole cell lysates (wcl) were analyzed by Western blotting for the presence of CdtB and 821 
RecA (as a cell lysis and loading control).  822 
 823 
Figure 2. TtsA mediates the transport of typhoid toxin to the trans side of the 824 
peptidoglycan layer  825 
(a-e) Wild-type and ∆ttsA S. Typhi carrying chromosomally-encoded FLAG-tagged CdtB 826 
(as a surrogate for typhoid toxin), DsbD, or SlyA (as indicated) were grown in TTIM for 827 
24 hs, fixed, mock treated or treated with lysozyme for 20 min (to permeabilize the PG 828 
layer), and stained as in Fig. 1 (a). To probe the TtsA-dependent translocation of typhoid 829 
toxin from the cis to the trans side of the PG layer, bacteria (wild-type and ∆ttsA mutant) 830 
were first treated with proteinase K for 30 min, followed by lysozyme or mock treatment 831 
for 20 min (c and e), or first treated with lysozyme for 20 min, followed by proteinase K 832 
treatment for 30 min (d). In all cases, the number of bacterial cells positive for CdtB, 833 
DsbD, or SlyA signals (green), was quantified relative to the total number of bacteria 834 
analyzed (LPS, red signal). The average ratios of green positive cells to red total cells ± 835 
standard deviation from 3 independent experiments are shown. In all cases, a total of 30 836 
images were collected from which 100 randomly selected bacteria (total number) per 837 
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image were analyzed, resulting in 3,000 bacterial cells analyzed per bacterial strain or 838 
condition (**** p < 0.0001, Student t Test) (Supplementary data set 2) (b-e).  839 
 840 
Figure 3. Typhoid toxin and TtsA localize to the bacterial poles 841 
(a and b) Typhoid toxin and TtsA localize to the bacterial poles after in vitro growth or 842 
cell infection. S. Typhi strains carrying chromosomally-encoded FLAG-tagged CdtB (as a 843 
surrogate for typhoid toxin) or TtsA were grown for 24 hours in TTIM, fixed, and stained 844 
with a mouse antibody directed to the FLAG-epitope (green) (to visualize CdtB or TtsA, 845 
as indicated) and a rabbit antibody directed to S. Typhi LPS (red) (a). Alternatively, the 846 
same S. Typhi strains were grown in LB (non inducing media), applied to cultured Henle-847 
407 human epithelial cells, and 24 hours post infection the infected cells were stained 848 
with an antibody directed to the FLAG-epitope (green) to visualize CdtB or TtsA (as 849 
indicated), a rabbit antibody directed to S. Typhi LPS (red), and DAPI for DNA detection 850 
(blue) (b) (scale bar: 5 µm). The diagrams to the right of each panel show fluorescence 851 
signal intensities for the corresponding FLAG-tagged protein distributed along the axes 852 
of individual bacterial cells. Twenty six measuring points were defined from the center 853 
(0) to each of the poles (1.0) of the bacterial cells and the distribution of the fluorescence 854 
intensity along the axes of bacteria were analyzed with the MicrobeJ plug-in of ImageJ 855 
(https://imagej.nih.gov/ij). The black line depicts the average of the intensities measured 856 
at each of the 26 measuring points. Data in each panel are from 1,800 individual 857 
measurements at each of the measuring points from 900 bacteria analyzed in opposite 858 
directions from the center. Insets show the quantification of the signal intensities at the 859 
measuring point furthest from the center (1.0), and at the center of each bacterium (0) 860 
for each condition. Numbers represent the mean ± SEM from 1,800 measurements (**** 861 
p < 0.0001, Student t Test) (Supplementary data set 3).  862 
 863 
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Figure 4. TtsA exerts its activity at the bacterial poles 864 
 (a) S. Typhi wild-type and the isogenic ∆ttsA mutant were grown in TTIM for 24 hs, and 865 
metabolically labeled by the addition of alkyne-D-alanine (2mM) for 240 minutes. 866 
Bacteria were then fixed and subsequently treated with an azido-AF488 fluorophore 867 
(10µM), which was then covalently linked by click chemistry to alkyne-D-alanine that had 868 
been incorporated into to the PG layer. (b and c) Growth-phase dependency of the PG 869 
remodeling at the bacterial poles. S. Typhi wild type and the isogenic ∆ttsA mutant were 870 
grown 24 hs in TTIM, and subsequently labeled metabolically by the addition of alkyne-871 
D-alanine (2mM) for 240 minutes. Bacteria cultures were then split into TTIM (mock) (c) 872 
or into TTIM containing 1 % casamino acids (both conditions in the presence of alkyne-873 
D-alanine) (b), which allows bacteria to re-enter the cell cycle (see Supplementary Fig. 874 
10). At the indicated time points bacteria were harvested and PG was labeled as 875 
indicated above. In all cases (a-c), the graphs showed the results of the line scan 876 
analysis of fluorescence intensity along the axes of individual bacterial cells as described 877 
in Fig. 3. The blue or red line depicts the average of the intensities measured at each of 878 
the measuring points. Data in each graph are from 1,800 individual measurements at 879 
each of the measuring points from 900 bacteria analyzed in opposite directions from the 880 
center. In each case insets show the average ratios of the signal intensities at the 881 
measuring point furthest from the center (1.0) to the measuring point at the center of 882 
each bacterium (0) (*** p < 0.001; **** p < 0.0001, n. s. differences not statistically 883 
significant, Student t Test) (Supplementary data set 4). (d) TtsA localization after re-884 
growth of S. Typhi in casamino acid-supplemented TTIM. Wild-type S. Typhi carrying 885 
chromosomally encoded FLAG-tagged TtsA was grown for 24 hs in TTIM to stationary 886 
phase. Bacteria were then transferred to TTIM containing casamino acids (1 %), which 887 
allows bacteria to re-enter the cell cycle, and 6 hs after, bacteria were fixed, treated with 888 
lysozyme (50 µg/ml) and Triton X-100 (0.3 %). TtsA was visualized by fluorescence 889 
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microscopy using a monoclonal antibody directed to the FLAG-epitope and a rabbit 890 
antibody directed to S. Typhi LPS (red) (to visualize bacterial cells) (scale bar: 5 µm). 891 
Graph shows the results of the line scan analysis of fluorescence intensity along the 892 
axes of individual bacterial cells as described in Fig. 3. The black line depicts the 893 
average of the intensities measured at each of the measuring points. Inset shows the 894 
quantification of the signal intensities at the measuring point furthest from the center 895 
(1.0), and at the center of each bacterium (0). Numbers represent the mean ± SEM from 896 
1,800 measurements (**** p < 0.0001, Student t Test) (Supplementary data set 4). 897 
 898 
Figure 5. YcbB-dependent peptidoglycan editing is required for typhoid toxin 899 
translocation across the bacterial envelope 900 
 (a–d) Contribution of LD-transpeptidases to typhoid toxin translocation. S. Typhi strains 901 
carrying the indicated mutations (all expressing chromosomally-encoded FLAG-tagged 902 
CdtB) were grown for 24 hs in TTIM, fixed, and stained with a mouse antibody directed 903 
to the FLAG-epitope (green) (to visualize typhoid toxin) and a rabbit antibody directed to 904 
S. Typhi LPS (red). The average ratios of the green/red fluorescence intensity ± 905 
standard deviation from 3 independent experiments are shown. In total 30 images were 906 
collected from which 100 randomly selected bacteria were analyzed resulting in 3,000 907 
bacterial cells analyzed per bacterial strain (**** p < 0.0001, Student t Test) 908 
(Supplementary data set 5) (a and c). Alternatively, Henle-407 cells were infected with 909 
the indicated S. Typhi strains and 24 hs post infection the infected cells were fixed and 910 
stained with an antibody directed to the FLAG epitope (green) to visualize typhoid toxin, 911 
a rabbit antibody directed to S. Typhi LPS (red) to visualize bacterial cells, and DAPI for 912 
DNA detection (blue). The quantification of the fluorescence intensity of typhoid toxin-913 
associated fluorescent puncta in infected cells, a measure of typhoid toxin carrier 914 
intermediates, is shown (b and d). Values represent relative fluorescence intensity and 915 
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are the mean ± standard deviation of three independent experiments in which at least 30 916 
images for each strain were analyzed. ****: p < 0.0001, Student t test (Supplementary 917 
data set 5). (e) YcbB-dependent polar remodeling of the peptidoglycan layer. S. Typhi 918 
wild-type or the isogenic ∆ycbB mutant were grown in TTIM for 24 hs, and metabolically 919 
labeled by the addition of alkyne-D-alanine (2mM) for 240 minutes as indicated in Fig. 4. 920 
The graph shows the results of the line scan analysis of fluorescence intensity along the 921 
axes of individual bacterial cells for wild-type (blue) and the ∆ycbB (green) S. Typhi 922 
strains carried out as described in Fig. 2. The blue or green line depicts the average of 923 
the intensities measured at each of the measuring points. Data are from 1,800 individual 924 
measurements at each of the measuring points from 900 bacteria analyzed in opposite 925 
directions from the center. Inset shows the average ratios of the signal intensities 926 
measured at the point furthest from the center (1.0) to the signal intensities measured 927 
center (0) of each bacterium. Numbers represent the mean ± standard deviations from 928 
1,800 measurements (*** p < 0.001, Student t Test) (Supplementary data set 5). (f) 929 
YcbB is enriched at the bacterial poles. S. Typhi strains carrying chromosomally-930 
encoded FLAG-tagged YcbB (green) or the control periplasmic protein DsbD (orange) 931 
were grown for 24 hours in TTIM, fixed, and stained with a mouse antibody directed to 932 
the FLAG-epitope. The graph shows fluorescence signal intensities for the 933 
corresponding FLAG-tagged protein distributed along the axes of individual bacterial 934 
cells and measured as described in Fig. 3. The green or orange lines depict the average 935 
of the intensities measured at each of the measuring points. Data are from 1,800 936 
individual measurements at each of the measuring points from 900 bacteria analyzed in 937 
opposite directions from the center. Inset shows the average ratios of the signal 938 
intensities measured at the point furthest from the center (1.0) to the signal intensities 939 
measured center (0) of each bacterium. Numbers represent the mean ± standard 940 
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deviation from 1,800 measurements (** p < 0.01, Student t Test) (Supplementary data 941 
set 5). 942 
 943 
Figure 6. TtsA activity requires YcbB-mediated peptidoglycan editing 944 
(a) Muropeptide profiles of different S. Typhi strains showing the YcbB-dependent PG 945 
editing. The indicated S. Typhi strains were grown 24 hs in TTIM, PG was isolated and 946 
analyzed by HPLC-MS. The identity of the most relevant peaks is noted based on 947 
comparison with the published profile from E. coli 31. The ycbB mutant shows a 948 
significant decrease in the monomeric disaccharide tripeptide (Tri) and the 3-3 cross-949 
linked muropeptides TriTri(Dap) and TetraTri(Dap). (b) YcbB-dependent growth arrest 950 
after sec-dependent TtsA translocation to the periplasmic space. S. Typhi wild type and 951 
the ∆ycbB isogenic mutant strain, both carrying a plasmid expressing ttsA containing a 952 
sec-secretion signal (sec-TtsA) under the control of an arabinose-inducible promoter, 953 
were grown in LB or TTIM media containing 0.001 % arabinose to induce the expression 954 
of ttsA, and the number of CFU was determined by plating in rich media after 24 hs of 955 
growth (***: p < 0.001, n. s. difference not statistically significant, Student t test). (c and 956 
d) The TtsA muramidase activity is dependent on YcbB. Peptidoglycan was isolated 957 
from wild-type S. Typhi grown in either LB, or TTIM, or from the ∆ycbB S. Typhi mutant 958 
grown in TTIM, as indicated. In-gel digestion zymograms were performed with equal 959 
amounts of purified wild-type TtsA, the catalytic mutant TtsAE14A, or lysozyme (shown in 960 
a coomassie stained PAGE, left panels) (c). Alternatively, the activity of purified TtsA  961 
and lysozyme (as a control) was evaluated using a turbidimetric assay using purified 962 
peptidoglycan preparations from wild-type S. Typhi grown in LB or in TTIM, or from the 963 
∆ycbB mutant grown in TTIM as indicated (d). Graphs show the mean turbidity 964 
(measured at OD540 nm) ± standard deviation of three independent experiments.  965 
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Figure 7. Model for the typhoid toxin secretion mechanism 967 
The different subunits of typhoid toxin (PltB, PltA, and CdtB) are secreted to the cis side 968 
of the periplasm by the sec pathway, where they assemble into the holotoxin complex 969 
(1). The muramidase TtsA introduces a fenestration in the YcbB-modified peptidoglycan 970 
layer at the bacterial poles allowing the passage of typhoid toxin to the trans side of the 971 
periplasmic space, positioning the toxin in close proximity to the outer membrane (2) 972 
from where it is released to the exterior upon minor disruptions to the outer membrane 973 
caused by various agonists encountered by S. Typhi during infection (3).  974 
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